These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38826833)
1. Usefulness of platelet count to predict concomitant valvular heart disease in patients with systemic lupus erythematosus. Usuku H; Yamamoto E; Sakata K; Hirata S; Toda A; Oike F; Tabata N; Ishii M; Hanatani S; Hoshiyama T; Sueta D; Kanazawa H; Arima Y; Takashio S; Matsuzawa Y; Kawano H; Yasunaga JI; Tsujita K Int J Cardiol Heart Vasc; 2024 Aug; 53():101420. PubMed ID: 38826833 [TBL] [Abstract][Full Text] [Related]
2. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis. Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225 [TBL] [Abstract][Full Text] [Related]
3. A Meta-analysis and Systematic Review of Valvular Heart Disease in Systemic Lupus Erythematosus and Its Association With Antiphospholipid Antibodies. Hussain K; Gauto-Mariotti E; Cattoni HM; Arif AW; Richardson C; Manadan A; Yadav N J Clin Rheumatol; 2021 Dec; 27(8):e525-e532. PubMed ID: 32558678 [TBL] [Abstract][Full Text] [Related]
6. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease. Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075 [TBL] [Abstract][Full Text] [Related]
7. Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study. Cai D; Zheng Z; Hu J; Fu Y; Song Y; Lian J Clin Rheumatol; 2024 Jan; 43(1):533-541. PubMed ID: 37505304 [TBL] [Abstract][Full Text] [Related]
8. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study. Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y; JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396 [TBL] [Abstract][Full Text] [Related]
9. Impact of Valvular Heart Disease on Mortality, Thromboembolic and Cardiac Events in Japanese Patients With Atrial Fibrillation - The Fushimi AF Registry. Doi K; Ogawa H; Ishigami K; Ikeda S; Aono Y; Hamatani Y; Fujino A; An Y; Ishii M; Iguchi M; Masunaga N; Esato M; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M; Circ J; 2020 Apr; 84(5):714-722. PubMed ID: 32213725 [TBL] [Abstract][Full Text] [Related]
11. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A; Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation). Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635 [TBL] [Abstract][Full Text] [Related]
13. Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients. Laurent M; Ennezat PV; Malergue MC; Bruneval P; Arch Cardiovasc Dis; 2022; 115(6-7):348-358. PubMed ID: 35697655 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China. Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873 [TBL] [Abstract][Full Text] [Related]
15. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study. Pang Y; Liu S; Yan L; Wang Q; Li L; Chu C; Ning J; Zhang B; Wang X; Ma S; Su D; Zhang R; Niu Y Ecotoxicol Environ Saf; 2021 Feb; 209():111753. PubMed ID: 33348255 [TBL] [Abstract][Full Text] [Related]
16. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients. Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease. Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy). Ezekowitz MD; Nagarakanti R; Noack H; Brueckmann M; Litherland C; Jacobs M; Clemens A; Reilly PA; Connolly SJ; Yusuf S; Wallentin L Circulation; 2016 Aug; 134(8):589-98. PubMed ID: 27496855 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease. Zhang B; Xu H; Zhang H; Liu Q; Ye Y; Hao J; Zhao Q; Qi X; Liu S; Zhang E; Xu Y; Gao R; Pibarot P; Clavel MA; Wu Y; J Am Coll Cardiol; 2020 Apr; 75(14):1659-1672. PubMed ID: 32273031 [TBL] [Abstract][Full Text] [Related]
20. Valvular heart disease by transthoracic echocardiography is associated with focal brain injury and central neuropsychiatric systemic lupus erythematosus. Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL Cardiology; 2007; 108(4):331-7. PubMed ID: 17299260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]